Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services, which are typically characterized by strong brand names, innovative technology, and major market positions.

The Company’s Life Sciences segment offers a broad range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites, and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The segment, through its Pall Corporation business, is also a leading provider of filtration, separation and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics and general industrial sectors. 

Company Growth (employees)
Washington, US
Size (employees)
62,000 (est)
Danaher was founded in 1969 and is headquartered in Washington, US

Key People at Danaher

Thomas Joyce

Thomas Joyce

President, Chief Executive Officer, Director
William Daniel

William Daniel

Executive Vice President
Brian Ellis

Brian Ellis

Senior Vice President, General Counsel
Angela Lalor

Angela Lalor

Senior Vice President, Human Resources
Daniel Raskas

Daniel Raskas

Senior Vice President, Corporate Development
Daniel Comas

Daniel Comas

Chief Financial Officer, Executive Vice President
William King

William King

Senior Vice President, Strategic Development
Robert Lutz

Robert Lutz

Senior Vice President, Chief Accounting Officer

Danaher Office Locations

Danaher has an office in Washington
Washington, US (HQ)
800w The Avenue 2200 Pennsylvania Ave NW

Danaher Metrics

Danaher Financial Metrics

Revenue (2016)

$16.9 b

Revenue growth (2015-16), %


Gross profit

$9.3 b

Gross profit margin (2016), %


Net income (2016)

$2.6 b

Market capitalization (21-Mar-2017)

$60 b

Closing share price (21-Mar-2017)


Cash (31-Dec-2016)

$963.7 m
Danaher's current market capitalization is $60 b.
Danaher's revenue was reported to be $16.9 b in FY, 2016 which is a 17.9% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$19.1 b$19.9 b$20.6 b$16.9 b

Revenue growth, %


Cost of goods sold

$9.2 b$9.5 b$9.8 b$7.5 b

Gross profit

$10 b$10.4 b$10.8 b$9.3 b

Gross profit Margin, %



$3.3 b$3.4 b$3.5 b$2.8 b

EBIT margin, %


Interest income

$5.7 m$16.7 m$5.3 m$200 k

Net Income

$2.7 b$2.6 b$3.4 b$2.6 b
FY, 2013FY, 2014FY, 2015FY, 2016


$3.1 b$3 b$790.8 m$963.7 m


$1.8 b$1.8 b$2.1 b$1.7 b

Current Assets

$9.1 b$9.4 b$7.8 b$6.7 b


$2.2 b$2.2 b$2.8 b$2.4 b


$16 b$17 b$25.1 b$23.8 b

Total Assets

$34.7 b$37 b$48.2 b$45.3 b

Accounts Payable

$1.8 b$1.9 b$2 b$1.5 b

Total Debt

$3.4 b$3.4 b$12 b$9.7 b

Current Liabilities

$4.5 b$5.4 b$6.2 b$6.9 b

Additional Paid-in Capital

$4.2 b$4.5 b$5 b$5.3 b

Retained Earnings

$18 b$20.3 b$21 b$20.7 b

Total Equity

$23.8 b$23.1 b

Debt to Equity Ratio

0.5 x0.4 x

Debt to Assets Ratio

0.1 x0.1 x0.2 x0.2 x

Financial Leverage

2 x2 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$2.7 b$2.6 b$3.4 b$2.6 b


$62.9 m$50.6 m$119.7 m$9.4 m

Cash From Operating Activities

$3.6 b$3.8 b$3.8 b$3.5 b

Cash From Investing Activities

($552.5 m)($3.4 b)($15 b)($5.2 b)

Cash From Financing Activities

($1.6 b)($218.2 m)$9.1 b$2 b

Danaher Market Value History

Danaher Online Presence

Danaher News

Danaher Company Life

You may also be interested in